NextCure (NXTC) Operating Leases (2022 - 2026)
NextCure (NXTC) posted quarterly Operating Leases of $3.9 million for Q1 2026, down 21.05% year-over-year from $4.9 million in Q1 2025, and down 6.49% quarter-over-quarter from $4.1 million in Q4 2025.
NextCure (NXTC) Operating Leases (2022 - 2026) Analysis & Trends
NextCure's Operating Leases history runs 5 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Operating Leases fell 21.05% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (down 21.05% YoY), while the FY2025 annual figure was $4.1 million, down 19.5% from the prior year.
- Operating Leases for Q1 2026 stood at $3.9 million, down from $4.1 million in the prior quarter.
- The five-year high for Operating Leases was $6.6 million in Q4 2022, with the low at $3.9 million in Q1 2026.
- The 5-year median for Operating Leases is $5.5 million (2024), against an average of $5.4 million.
- The sharpest annual moves came in 2023 and 2026: Operating Leases fell 9.93% in 2023, then fell 21.05% in 2026.
- NextCure's Operating Leases stood at $6.6 million in 2022, then decreased by 9.93% to $5.9 million in 2023, then decreased by 13.38% to $5.2 million in 2024, then decreased by 19.5% to $4.1 million in 2025, then dropped by 6.49% to $3.9 million in 2026.
- Business Quant data shows NXTC's Operating Leases at $3.9 million in Q1 2026, $4.1 million in Q4 2025, and $4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.60 Mn |
| Mar 31, 2026 | 3.88 Mn |
| Dec 31, 2025 | 4.15 Mn |
| Sep 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | 4.67 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Dec 31, 2024 | 5.15 Mn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 5.59 Mn |
| Mar 31, 2024 | 5.77 Mn |
| Dec 31, 2023 | 5.95 Mn |
| Sep 30, 2023 | 6.12 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | 6.45 Mn |
| Dec 31, 2022 | 6.61 Mn |